NIH Launches Home Test to Treat, a Pilot COVID-19 Telehealth Program
NIH and ASPR, launch Home Test to Treat, a virtual health intervention to provide free COVID-19 health services in selected communities.
NIH and ASPR, launch Home Test to Treat, a virtual health intervention to provide free COVID-19 health services in selected communities.
C. Michael White, a professor of pharmacy practice, and Adrian V. Hernandez, a clinical epidemiologist, both from the University of Connecticut, explain how the Biden administration’s new “test to treat” initiative will make use of pharmacies.
Mild symptoms, poor knowledge of nearby testing sites, and certain demographic factors have been identified as barriers to COVID-19 testing.
The Opti SARS-CoV-2 RT-PCR Test has received FDA Emergency Use Authorization and CE-IVD for sample handling using the OPTI Rapid Lysis Buffer.
Read MoreHospitals are charging up to $650 for a molecular covid test that costs $50 or less to run, according to Medicare claims analyzed by Hospital Pricing Specialists (HPS).
Read MoreScientists and lawmakers agree that over-the-counter COVID-19 tests could allow desk workers to settle back into their cubicles and make it easier to reopen schools and travel.
Read MoreThe FDA granted marketing authorization to the BioFire Respiratory Panel 2.1, the first SARS-CoV-2 diagnostic test permitted to be marketed beyond the COVID-19 public health emergency.
Read MoreResearchers have proposed a new quantitative strategy for pooling COVID-19 tests in order to monitor spread and detect outbreaks early within closed communities, such as nursing homes or universities.
Read MoreThe US FDA has issued an emergency use authorization (EUA) for the Cue COVID-19 Test for Home and Over The Counter Use.
Read MoreA new COVID-19 antibody assay was able to detect IgG and IgM antibodies to determine viable donor samples for therapeutic use and clinical trials.
Read MoreAccording to Spectrum Solutions, the company’s saliva-based COVID-19 home test will be rolled out to the United Kingdom as part of the country’s efforts to test its entire population, weekly.
Read MoreRheonix Inc received an expanded FDA emergency use authorization that allows the use of saliva as an approved sample type.
Read MoreLabCorp’s Pixel COVID-19 Test Home Collection Kit has been authorized for emergency use by the FDA — the first COVID-19 direct-to-consumer (non-prescription) test system.
Read MoreThe US FDA issued a new emergency use authorization for Abbott’s BinaxNow COVID-19 Ag Card Home Test, which is now authorized for use by patients at home with a prescription.
Read MoreStanford Medicine is seeking volunteers for a study of an at-home, COVID-19 saliva test that’s designed to cost $5 or less, use no electricity and provide fast and accurate results.
Read More